COVID-19: SARS-CoV-2 Transmission Probable Through Fecal Aerosols
A case of COVID-19 transmission in a high-rise apartment complex in China demonstrates the probable transmission of SARS-CoV-2 through fecal aerosols.
Emerging Diseases
Likely Deficient Vitamin D Status Linked to COVID-19 Risk
Likely deficient vitamin D status is associated with an increased risk for COVID-19.
California Has First Plague Case in Five Years
California’s first case of plague in five years has been confirmed by health officials.
Emergency Use Authorization Issued for COVID-19 Convalescent Plasma
The EUA was based on historical evidence indicating some effectiveness with convalescent plasma use in previous outbreaks of respiratory viruses, preclinical data, results from small clinical trials, and data from the National Expanded Access Treatment Protocol sponsored by the Mayo Clinic.
COVID-19: Anosmia Predictive of Less Severe Infection
Current guidelines from Italy, the UK, and China do not focus on screening patients for anosmia as a potential symptom for COVID-19.
New Drug Application for Remdesivir Submitted
Remdesivir is an investigational nucleotide analogue with broad-spectrum antiviral activity.
Convalescent Plasma Transfusion Appears Safe for Patients With COVID-19
The transfusion of human convalescent plasma as a mitigation and treatment option for patients with COVID-19 is associated with a low rate of serious adverse events.
Necessary Improvements of WHO Ebola Case Definitions Needed
Current WHO Ebola case definitions perform suboptimally at case identification in both community and clinical triage settings.
Assessing Prone and Lateral Positioning in COVID-19 With Hypoxemic Respiratory Failure
Patients with hypoxemic acute respiratory failure because of COVID-19 who received CPAP therapy had a high failure rate during prone/lateral positioning tests.
Glucocorticoids Plus Tocilizumab May Improve Respiratory Outcomes in COVID-19-Related Cytokine Storm Syndrome
Researchers assessed the effect of treatment with glucocorticoids and tocilizumab in patients with severe COVID-19-associated cytokine storm syndrome.
-
Loading...
-
Loading...
Next post in COVID19
